This report summarizes the key takeaways from an October 2020 virtual roundtable on antimicrobial resistance (AMR) and explores the multifaceted risks posed by AMR in aging societies globally, and Japan in particular. The roundtable was co-organized by GCOA and the Health and Global Policy Institute (HGPI) and sponsored by Pfizer Japan. Click here to read the full press…

GCOA and Pfizer Global Medical Grants launched a $1 million grant program to improve uptake of vaccines among Japanese older adults. The Vaccines for All: Longevity Unleashed for Everyone (VALUE) initiative will support, advance, and validate quality improvement strategies that measurably increase the number of older adults in Japan who are immunized against at least one targeted vaccine-preventable…

In June 2019, GCOA partnered with the Tokyo-based Health and Global Policy Institute to convene a policy roundtable alongside the G20 Finance Ministers Meeting. Held at the Nikkei Head Office in Tokyo, the roundtable brought together a select group of cross-sector experts to share their insights on moving vaccine policies forward and positioning vaccine policies within the…

In November 2018, GCOA partnered with the Tokyo-based Health and Global Policy Institute to convene an expert meeting on “The Impact of Innovation Across Technology, Health, Care and Urban Design for Super-Ageing Societies.” The meeting brought together 30-40 top Japanese and global experts across academia, government, NGOs, and the private sector to exchange views and gain…

In October 2015, the World Economic Forum’s Global Agenda Council on Ageing produced a white paper titled, ‘How 21st-Century Longevity Can Create Markets and Drive Economic Growth’, which underpins that business is on the brink of a new, innovative, and imperative opportunity that also has the potential to play a central role in transforming global…